Form 8-K - Current report:
SEC Accession No. 0001185185-25-002055
Filing Date
2025-12-15
Accepted
2025-12-15 16:02:27
Documents
15
Period of Report
2025-12-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K igc8k121525.htm   iXBRL 8-K 28722
2 EXHIBIT 3.1 igcex3-1.htm EX-3.1 777
3 GRAPHIC image_001.jpg GRAPHIC 5199
4 GRAPHIC ex3-1_001.jpg GRAPHIC 341483
  Complete submission text file 0001185185-25-002055.txt   680268

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE igc-20251212.xsd EX-101.SCH 3010
6 XBRL LABEL FILE igc-20251212_lab.xml EX-101.LAB 34235
7 XBRL PRESENTATION FILE igc-20251212_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT igc8k121525_htm.xml XML 3659
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-529-4996
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32830 | Film No.: 251571518
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)